"Psychotropic Drugs" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A loosely defined grouping of drugs that have effects on psychological function. Here the psychotropic agents include the antidepressive agents, hallucinogens, and tranquilizing agents (including the antipsychotics and anti-anxiety agents).
| Descriptor ID |
D011619
|
| MeSH Number(s) |
D27.505.954.427.700
|
| Concept/Terms |
Psychotropic Drugs- Psychotropic Drugs
- Drugs, Psychotropic
- Psychopharmaceuticals
- Psychoactive Agents
- Agents, Psychoactive
- Psychoactive Drugs
- Drugs, Psychoactive
|
Below are MeSH descriptors whose meaning is more general than "Psychotropic Drugs".
Below are MeSH descriptors whose meaning is more specific than "Psychotropic Drugs".
This graph shows the total number of publications written about "Psychotropic Drugs" by people in this website by year, and whether "Psychotropic Drugs" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 1 | 1 |
| 2000 | 1 | 0 | 1 |
| 2006 | 0 | 1 | 1 |
| 2007 | 0 | 2 | 2 |
| 2008 | 1 | 0 | 1 |
| 2011 | 1 | 1 | 2 |
| 2012 | 0 | 1 | 1 |
| 2014 | 0 | 1 | 1 |
| 2016 | 0 | 1 | 1 |
| 2017 | 1 | 0 | 1 |
| 2018 | 1 | 0 | 1 |
| 2021 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Psychotropic Drugs" by people in Profiles.
-
Psychotropic Drug Treatment Patterns in Persons with Fragile X Syndrome. J Child Adolesc Psychopharmacol. 2021 12; 31(10):659-669.
-
Longitudinal Effects of Activities, Social Environment, and Psychotropic Medication Use on Behavioral Symptoms of Individuals With Alzheimer's Disease in Nursing Homes. J Psychosoc Nurs Ment Health Serv. 2018 Nov 01; 56(11):18-26.
-
Effect of the mGluR5-NAM Basimglurant on Behavior in Adolescents and Adults with Fragile X Syndrome in a Randomized, Double-Blind, Placebo-Controlled Trial: FragXis Phase 2 Results. Neuropsychopharmacology. 2018 02; 43(3):503-512.
-
Ethical challenges in developing drugs for psychiatric disorders. Prog Neurobiol. 2017 05; 152:58-69.
-
Importance of a specialty clinic for individuals with fragile X syndrome. Am J Med Genet A. 2016 12; 170(12):3144-3149.
-
A 12-week comparison regarding symptom improvement in an urban university-based outpatient child psychiatry clinic. Am J Ther. 2014 Jan-Feb; 21(1):10-4.
-
Psychometric study of the Aberrant Behavior Checklist in Fragile X Syndrome and implications for targeted treatment. J Autism Dev Disord. 2012 Jul; 42(7):1377-92.
-
The Movement Disorder Society Evidence-Based Medicine Review Update: Treatments for the non-motor symptoms of Parkinson's disease. Mov Disord. 2011 Oct; 26 Suppl 3:S42-80.
-
Therapeutic strategies in fragile X syndrome: dysregulated mGluR signaling and beyond. Neuropsychopharmacology. 2012 Jan; 37(1):178-95.
-
Impact of concurrent naturalistic pharmacotherapy on psychotherapy of complicated grief. Psychiatry Res. 2008 May 30; 159(1-2):31-6.